Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Edarbi. Always confirm against the full prescribing information.
100 interactions
Aceclofenac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Aceclofenac.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Acetylsalicylic acid.
Level 1 evidence
Alogliptin
The risk or severity of angioedema can be increased when Alogliptin is combined with Azilsartan medoxomil.
Level 2 evidence
Alteplase
The risk or severity of angioedema can be increased when Alteplase is combined with Azilsartan medoxomil.
Level 2 evidence
Amiloride
The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Amiloride.
Level 1 evidence
Amobarbital
Amobarbital may increase the hypotensive activities of Azilsartan medoxomil.
Level 2 evidence
Antipyrine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Antipyrine.
Level 1 evidence
Aripiprazole
The risk or severity of hypotension can be increased when Aripiprazole is combined with Azilsartan medoxomil.
Level 1 evidence
Aripiprazole lauroxil
The risk or severity of hypotension can be increased when Aripiprazole lauroxil is combined with Azilsartan medoxomil.
Level 1 evidence
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Azilsartan medoxomil.
Level 1 evidence
Balsalazide
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Balsalazide.
Level 1 evidence
Benazepril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Benazepril is combined with Azilsartan medoxomil.
Level 1 evidence
Enter your NPI to unlock 2 major interactions for Edarbi
Edarbi (Azilsartan Kamedoxomil) has 393 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Edarbi (Azilsartan Kamedoxomil) has 7 major, 138 moderate, and 248 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Edarbi. Always confirm against the full prescribing information.